drugset / Trial / NCT01710696

Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome

NCT01710696

Phase 3 Completed 50 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of the trial is to induce normal pubertal development in girls with Turner Syndrome in accordance with that of their peers and their individual state psychosocial maturation.

Timeline

Start
1998-07-23
Primary completion
2004-07-26
Completion
2004-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject 17-beta estradiol Unknown 0.5 ug Oral
Subject 17-beta estradiol Unknown 5 ug/kg Oral
Subject 17-beta estradiol Unknown 15 ug/kg Oral

Indications